← Back to Vaccine Database

Covigenix VAX-001-DNA vaccines + proteo-lipid vehicle (PLV) formulation

DNA based vaccine · VDDBV0181

Target & Classification

SARS-CoV-2SARS-CoV-2
DNA based vaccine
COVID-19
Phase 1

Clinical Development

Phase 1
Phase 2
Phase 3
Approved

Clinical Trials1

NCT IDPhaseDisease / Condition
NCT04591184 Phase 1COVID-19